Product: | Batimastat | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 17367 | ||||||||
CAS Number: | 130370-60-4 | ||||||||
Pricing: |
|
||||||||
Formula: | C23H31N3O4S2 | ||||||||
Chemical Purity: | >98% | ||||||||
Molecular Weight: | 477.64 | ||||||||
Structure: | |||||||||
Appearance: | Solid | ||||||||
Category: | Anti-cancer compounds | ||||||||
Stability: | Stable under recommended storage conditions. | ||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C. |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
Walker EJ, Rosenberg GA, Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia. J. Neurosci. Res. 4, 764-73, (2010); Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E.,, Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J. Pathol. 4, 538-45, (2001); Krüger A, Soeltl R, Sopov I, Kopitz C, Arlt M, Magdolen V, Harbeck N, Gänsbacher B, Schmitt M.,, Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. Cancer Res. 4, 1272-5, (2001) |
||||||||
MSDS: | |||||||||
Description: |
Batimastat is a potent, broad spectrum matrix metalloprotease (MMP) inhibitor |